News
Harrow s'associe à une filiale du groupe privé Nordic Group pour le lancement d'un générique autorisé de la suspension ...
Nordic Pharma, Inc., une filiale de Nordic Group B.V., a annoncé un partenariat avec Harrow pour lancer un générique autorisé ...
Purpose: The stability of a triamcinolone acetonide mouthwash and its efficacy in treating oral lichen planus are described. Results: The mouthwash had a satisfactory shelf life and was well ...
Pacira BioSciences, Inc.’s PCRX share price has surged by 5.48%, which has investors questioning if this is right time to ...
Sharon Lokedi a battu le record de l’épreuve chez les femmes en 2 h 17 min 22 s, tandis que son compatriote a réalisé la ...
Intralesional corticosteroids (such as triamcinolone acetonide, 2.5-10 mg/cc) are frequently effective in treating inflamed acne cysts and nodules. Newer treatments for acne include high-intensity ...
has approved Harrow’s transitional pass-through application for TRIESENCE® (triamcinolone acetonide injectable suspension) 40 mg/mL, a preservative-free synthetic corticosteroid that is ...
New seasonal allergies in adulthood can result from a genetic predisposition, exposure to new allergens, changes to your ...
Reinforces confidence in 5x30 plan - -- Continued focus on margin expansion and operational efficiency -- BRISBANE, Calif., April 17 ...
The following is a summary of “Prediction of radiosensitivity in non-small cell lung cancer based on computed tomography and tumor genomics: a multiple real-world cohort study,” published in the April ...
The following is a summary of “Health Equity and Emergency Colorectal Surgery in the United States: A Scoping Review,” published in the March 2025 issue of the Journal of Surgical Research by Byrd et ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results